Brief: Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09/05/2024 12:46
May 9 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS ANNOUNCES UNBLINDING OF THE BUNTANETAP PHASE III
DATA IN
PARKINSON’S DISEASE
* ANNOVIS BIO INC - TOPLINE EFFICACY DATA IS EXPECTED IN
JUNE
Source text for Eikon: ID:nGNX6sl1kn
Further company coverage: ANVS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman